Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Mounjaro is FDA-approved to help treat type 2 diabetes
Both cash pay and insurance are accepted
Iran War Spokane Wildfires World Politics Entertainment HealthWatch MoneyWatch Crime Space Sports Brand Studio The Free Press Local News Atlanta Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas Live CBS News 24/7 Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas 48 Hours 60 Minutes Shows 48 Hours 60 Minutes CBS Evening News CBS Mornings CBS Morning News CBS Reports CBS Saturday Morning The Daily Report The Dish Face the Nation Sunday Morning The Takeout Things That Matter The Uplift CBS News Investigates CBS News Confirmed Podcasts Newsletters Download Our App CBS News Team Executive Team Brand Studio Paramount+ Join Our Talent Community RSS Feeds CBS Evening News | Full Episodes On the Road Watch CBS News New weight-loss drug Retatrutide showing stronger results than current options A new weight-loss drug, so new it is not on the market yet, is showing promising results in trials, doing much more than what current medications can
Tirzepatide is the chemical name of the active ingredient, while Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management) are the proprietary brand names manufactured by Eli Lilly and Company
Many patients prescribed Wegovy have pre-existing conditions such as type 2 diabetes or prediabetes, which are independent risk factors for recurrent yeast infections due to elevated blood glucose levels that favour Candida proliferation
US$ 26.72
US$ 24.94
US$ 27.14
US$ 23.80
US$ 20.40
US$ 27.73
US$ 27.26
US$ 27.15
US$ 23.93
US$ 26.46
US$ 27.82
